Alaunos Therapeutics, Inc. logo

TCRTAlaunos Therapeutics, Inc.

TCRT Stock Price, Valuation & Chart | Alaunos Therapeutics, Inc.

Compare

TCRT Historical price chart

TCRT Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization4.08M
PE Ratio-0.86
EPS-1.95
Trading Volume8.50K
Today's High/Low1.7/1.59
Dividend Yield0.00
52 Week High/Low4.59/1.55
Shares Outstanding2.44M
TCRT Financial Statement
TCRT Analyst ratings
TCRT Analysis & performance metrics

TCRT Company profile

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in…

TCRT Management team

Management
Melinda Lackey
Senior Vice President of Legal, Administration & Secretary
Ferdinand Groenewald
Vice President of Finance
Dale Curtis Hogue Jr.CEO
Interim Chief Executive Officer & Director
Total 3 executives

TCRT Frequently asked questions

What is Alaunos Therapeutics, Inc. (TCRT) Stock Price?

Current stock price of Alaunos Therapeutics, Inc. (TCRT) stock is $1.670. The stock price is +0.60% higher in the session. The intraday range can be seen from this page. Volume of Alaunos Therapeutics, Inc. (TCRT) stock is 8.50K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Alaunos Therapeutics, Inc. (TCRT) stock price going up or down today?

The stock price of Alaunos Therapeutics, Inc. (TCRT) can change with earnings, company news, and overall market sentiment. Alaunos Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Alaunos Therapeutics, Inc. stock expensive at its current price?

Whether Alaunos Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for TCRT on this page is -0.86. EPS on this page is -1.95. Compare those figures with peers and growth expectations before deciding if the current Alaunos Therapeutics, Inc. price is justified.

How has the stock price of Alaunos Therapeutics, Inc. (TCRT) performed historically?

Historical performance for Alaunos Therapeutics, Inc. (TCRT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how TCRT reacted to past earnings and market events.

Should I buy Alaunos Therapeutics, Inc. (TCRT) stock, at this price?

Buying Alaunos Therapeutics, Inc. (TCRT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.